AI-based electrocardiogram (ECG) technology developer AliveCor announced that it received FDA clearance for its next-gen ECG algorithms. Mountain View, Calif.-based AliveCor’s next-gen interpretive ECG algorithms, called Kardia AI V2, offers users a way to take a 30-second ECG and receive instant determinations of multiple cardiac conditions through the company’s KardiaMobile and KardiaMobile 6L devices and the […]
Cardiovascular
Chong Kun Dang to sell SkyLabs heart-monitoring ring in Korea
Pharmaceutical company Chong Kun Dang next month will start selling a heart-monitoring ring made by startup SkyLabs, according to Korean media reports. Chong Kun Dang paid ₩2.5 billion ($2.2 million) to SkyLabs for the right to sell the CART-I cardio tracker to consumers in South Korea, The Korea Herald reported today. Worn on a finger, […]
Boston Scientific’s Lotus layoffs extend to Ireland
Boston Scientific (NYSE:BSX) has reportedly confirmed job losses at its Galway, Ireland, location, following the retirement of the Lotus Edge. Galway Bay FM reported today that the Marlborough, Mass.-based company confirmed the job losses at its Ireland location, adding that Boston Scientific confirmed the job loss will affect fewer than 30 employees. The report said that […]
Boston Scientific to lay off 106 following Lotus Edge heart valve retirement
Boston Scientific (NYSE:BSX) is set to lay off 106 employees in Minnesota following the retirement of its Lotus Edge device, according to reports. Bring Me the News reported that the company is permanently laying off the 106 workers at its Maple Grove, Minn. location, having notified the state of Minnesota via a WARN letter, as is […]
Boston Scientific throws in the towel on Lotus TAVR
Boston Scientific (NYSE:BSX) announced today that it has initiated a global, voluntary recall of its Lotus Edge aortic valve system — and is immediately retiring the Lotus program. Marlborough, Mass.-based Boston Scientific said in a news release that the recall of all unused inventory of its Lotus Edge transcatheter aortic valve repair (TAVR) system is due […]
Study: Medtronic touts cryoablation results are better than medication
Medtronic (NYSE:MDT) today announced successful results from its STOP AF First clinical trial for cryoablation treatment. Published in the New England Journal of Medicine, results showed that cryoablation with the Arctic Front Advance Cardiac Cryoballoon and Freezor MAX cardiac cryoablation catheter is superior as a first-line treatment for preventing atrial arrhythmia recurrence compared to the use […]
AliveCor closes $65M Series E
AI-based electrocardiogram (ECG) technology developer AliveCor announced today that it has closed a $65 million Series E financing round. Mountain View, Calif.-based AliveCor plans to use proceeds from the financing round to accelerate the growth of its remote cardiology platform, both domestically and globally, according to a news release. AliveCor is augmenting its artificial intelligence-powered […]
Study: ECMO ‘significantly’ improves heart attack patients’ survival
The National Institutes of Health (NIH) is touting a study that found the use of life support improved survival in certain cardiac arrest patients. Published in The Lancet, the study, known as the Advanced Reperfusion Strategies for Refractory Cardiac Arrest (ARREST) trial, used the life support machine called extracorporeal membrane oxygenation ECMO to replicate the […]
Acutus appoints chief translational science officer
Acutus Medical (NSDQ:AFIB) announced that it appointed Dr. Steven Mickelsen as its chief translational science officer. Carlsbad, Calif.-base Acutus, which develops cardiac mapping technology, said in a news release that Mickelsen is set to guide the company’s vision to deliver the “most advanced electrophysiology therapeutic solutions on the market for physicians and their patients.” Mickelsen […]
DTW Podcast: Where will Intuitive find future growth? Abbott’s Moat on how population boom will boost demand
In this episode of the DeviceTalks Weekly Podcast, we’ll talk with Intuitive Surgical’s Julian Nikolchev, senior vice president, corporate development and strategy, and Dr. Oliver Keown, director of Intuitive Ventures, about the new $100 million venture fund. How will the capital be invested? Where does Intuitive see the opportunity, and how does the program fit […]
Medtronic has a Class I recall involving balloon catheters to treat heart defects
FDA today designated a Medtronic recall of Rashkind balloon septostomy catheters as Class I, its most serious level. The balloon catheters create an atrial septal defect or to enlarge an existing atrial septal defect in order to treat congenital heart defects. Medtronic (NYSE:MDT) initiated a recall of the Rashkind balloon septostomy catheters in late August after […]
